Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Seibold

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Digestion|July 19, 2005
Food-induced immune responses as origin of bowel disease?Frank Seibold
Inflammatory Bowel Diseases|September 26, 2008
What is the optimal maintenance treatment for Crohn's disease?Frank Seibold
Inflammatory Bowel Diseases|December 10, 2009
Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease?Frank Seibold, Alain M Schoepfer
Diseases of the Colon and Rectum|November 11, 2006
Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitisBrigitt Brunner, Ulrich Scheurer, Frank Seibold
The Journal of Clinical Investigation|September 15, 2007
TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseasesMirjam Schenk, Axel Bouchon, Frank Seibold, et al.
Scandinavian Journal of Gastroenterology|November 4, 2005
Treatment-resistant lingual Crohn's disease disappears after infliximabBrigitte Brunner, Claudia Hirschi, Rosemarie Weimann, et al.
Swiss Medical Weekly|June 28, 2011
Treatment algorithm for moderate to severe ulcerative colitisMichael Manz, Pierre Michetti, Frank Seibold, et al.
Scandinavian Journal of Gastroenterology|August 19, 2016
Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levelsMarijana Protic, Alain Schoepfer, Nikhil Yawalkar, et al.
United European Gastroenterology Journal|March 12, 2016
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case seriesThomas Greuter, Luc Biedermann, Gerhard Rogler, et al.
Journal of Crohn'S & Colitis|March 27, 2012
Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activityThomas Schaffer, Beatrice Flogerzi, Alain M Schoepfer, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Digestion|July 19, 2005
Food-induced immune responses as origin of bowel disease?Frank Seibold
Inflammatory Bowel Diseases|September 26, 2008
What is the optimal maintenance treatment for Crohn's disease?Frank Seibold
Inflammatory Bowel Diseases|December 10, 2009
Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease?Frank Seibold, Alain M Schoepfer
Diseases of the Colon and Rectum|November 11, 2006
Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitisBrigitt Brunner, Ulrich Scheurer, Frank Seibold
The Journal of Clinical Investigation|September 15, 2007
TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseasesMirjam Schenk, Axel Bouchon, Frank Seibold, et al.
Scandinavian Journal of Gastroenterology|November 4, 2005
Treatment-resistant lingual Crohn's disease disappears after infliximabBrigitte Brunner, Claudia Hirschi, Rosemarie Weimann, et al.
Swiss Medical Weekly|June 28, 2011
Treatment algorithm for moderate to severe ulcerative colitisMichael Manz, Pierre Michetti, Frank Seibold, et al.
Scandinavian Journal of Gastroenterology|August 19, 2016
Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levelsMarijana Protic, Alain Schoepfer, Nikhil Yawalkar, et al.
United European Gastroenterology Journal|March 12, 2016
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case seriesThomas Greuter, Luc Biedermann, Gerhard Rogler, et al.
Journal of Crohn'S & Colitis|March 27, 2012
Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activityThomas Schaffer, Beatrice Flogerzi, Alain M Schoepfer, et al.
Pageof 8